{"id":10849,"date":"2017-04-27T10:54:28","date_gmt":"2017-04-27T10:54:28","guid":{"rendered":"https:\/\/cells4life.com\/?p=10849"},"modified":"2018-11-21T09:24:10","modified_gmt":"2018-11-21T09:24:10","slug":"first-usa-trial-using-umbilical-cord-tissue-to-treat-autism","status":"publish","type":"post","link":"https:\/\/cells4life.com\/us\/2017\/04\/first-usa-trial-using-umbilical-cord-tissue-to-treat-autism\/","title":{"rendered":"First USA trial using umbilical cord tissue to treat autism"},"content":{"rendered":"[et_pb_section bb_built=”1″ admin_label=”section” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” custom_padding=”0px|||” padding_mobile=”on” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” custom_padding_tablet=”0px|||”][et_pb_row admin_label=”row” background_position=”top_left” background_repeat=”repeat” background_size=”initial”][et_pb_column type=”4_4″][et_pb_text background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” background_position=”top_left” background_repeat=”repeat” background_size=”initial”]\n

This month saw publication of the results of a groundbreaking new trial into umbilical cord blood as a treatment for autism<\/a>. The study showed enormous promise, with 75% of children showing an improvement in their condition.<\/p>\n

The medical centre responsible; Duke University, have now announced another ground breaking trial looking at umbilical cord tissue<\/a>.<\/p>\n[\/et_pb_text][et_pb_image src=”https:\/\/cells4life.com\/us\/wp-content\/uploads\/2017\/04\/autism_infographic.jpg” alt=”Cord blood and tissue stem cells and autism” title_text=”Autism in the UK” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” animation=”off” sticky=”off” align=”center” force_fullwidth=”off” always_center_on_mobile=”on” use_border_color=”off” border_color=”#ffffff” border_style=”solid” animation_style=”none” animation_duration=”1000ms” animation_intensity_slide=”50%” show_bottom_space=”on” \/][et_pb_text background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” background_position=”top_left” background_repeat=”repeat” background_size=”initial”]\n

Due to start in May 2017, the new study will determine the safety of intravenous infusions of human umbilical cord tissue derived mesencyhmal stem cells (MSC) in children with autism spectrum disorder.<\/p>\n

Children participating in the study will receive up to three separate infusions two months apart at Duke University, North Carolina with results published in 2019.<\/p>\n

Stem cell treatments for autism<\/h3>\n

Duke has a long established record using cord blood to treat to neurological conditions, such as autism, cerebral palsy and stroke, however, this is the first time an academic centre in the USA has registered a trial of this nature using stem cells from cord tissue.<\/p>\n[\/et_pb_text][et_pb_text background_layout=”dark” text_orientation=”left” background_color=”#00abc9″ use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_padding=”10px|10px|10px|10px” background_position=”top_left” background_repeat=”repeat” background_size=”initial”]\n

Cord blood and cord tissue trials – autism<\/strong><\/h3>\n